Peter L. Samuels

Rapamycin/IL-2 Combination Therapy in Patients With Type 1 Diabetes Augments Tregs yet Transiently Impairs β-Cell Function

S. Alice Long, Mary Rieck, Srinath Sanda et al. · Diabetes · 2012 · 306 citations · Full text

In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive T _regs Involves IL-6–Mediated Signaling

Anya Schneider, S. Alice Long, Karen Cerosaletti et al. · Science Translational Medicine · 2013 · 150 citations

ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors

Paul L. Bollyky, Rebecca P. Wu, Ben Falk et al. · Proceedings of the National Academy of Sciences · 2011 · 138 citations · Full text

Adaptive Immune System, T-regulatory Cell, Immunology +20

Tumour necrosis factor-α induces cyclo-oxygenase-2 gene expression in first trimester trophoblasts: suppression by glucocorticoids and NSAIDs

Hytham M. Imseis, Peter D. Zimmerman, Peter L. Samuels et al. · Placenta · 1997 · 49 citations

Inflammation, Apoptosis, Immunology +6

Dynamic Immune Phenotypes of B and T Helper Cells Mark Distinct Stages of T1D Progression

Tania Habib, S. Alice Long, Peter L. Samuels et al. · Diabetes · 2019 · 25 citations · Full text